These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 37756050)

  • 21. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
    During MJ; Kaplitt MG; Stern MB; Eidelberg D
    Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Technology in Parkinson's disease: Challenges and opportunities.
    Espay AJ; Bonato P; Nahab FB; Maetzler W; Dean JM; Klucken J; Eskofier BM; Merola A; Horak F; Lang AE; Reilmann R; Giuffrida J; Nieuwboer A; Horne M; Little MA; Litvan I; Simuni T; Dorsey ER; Burack MA; Kubota K; Kamondi A; Godinho C; Daneault JF; Mitsi G; Krinke L; Hausdorff JM; Bloem BR; Papapetropoulos S;
    Mov Disord; 2016 Sep; 31(9):1272-82. PubMed ID: 27125836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.
    von Linstow CU; Gan-Or Z; Brundin P
    Transl Neurodegener; 2020 Oct; 9(1):39. PubMed ID: 33066808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Right care, first time: a highly personalised and measurement-based care model to manage youth mental health.
    Hickie IB; Scott EM; Cross SP; Iorfino F; Davenport TA; Guastella AJ; Naismith SL; Carpenter JS; Rohleder C; Crouse JJ; Hermens DF; Koethe D; Markus Leweke F; Tickell AM; Sawrikar V; Scott J
    Med J Aust; 2019 Nov; 211 Suppl 9():S3-S46. PubMed ID: 31679171
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The current and projected economic burden of Parkinson's disease in the United States.
    Kowal SL; Dall TM; Chakrabarti R; Storm MV; Jain A
    Mov Disord; 2013 Mar; 28(3):311-8. PubMed ID: 23436720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease.
    Ferrer I; Martinez A; Blanco R; Dalfó E; Carmona M
    J Neural Transm (Vienna); 2011 May; 118(5):821-39. PubMed ID: 20862500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotective approaches to halt Parkinson's disease progression.
    Sola P; Krishnamurthy PT; Kumari M; Byran G; Gangadharappa HV; Garikapati KK
    Neurochem Int; 2022 Sep; 158():105380. PubMed ID: 35718278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Use of Digital Technology and Media in German Parkinson's Disease Patients.
    Marxreiter F; Buttler U; Gassner H; Gandor F; Gladow T; Eskofier B; Winkler J; Ebersbach G; Klucken J
    J Parkinsons Dis; 2020; 10(2):717-727. PubMed ID: 31424420
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological treatment of Parkinson disease: a review.
    Connolly BS; Lang AE
    JAMA; 2014 Apr 23-30; 311(16):1670-83. PubMed ID: 24756517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive behavioral therapy improves diverse profiles of depressive symptoms in Parkinson's disease.
    Dobkin RD; Mann SL; Interian A; Gara MA; Menza M
    Int J Geriatr Psychiatry; 2019 May; 34(5):722-729. PubMed ID: 30714202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in markers of prodromal Parkinson disease.
    Postuma RB; Berg D
    Nat Rev Neurol; 2016 Oct; 12(11):622-634. PubMed ID: 27786242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease.
    Prediger RD; Aguiar AS; Moreira EL; Matheus FC; Castro AA; Walz R; De Bem AF; Latini A; Tasca CI; Farina M; Raisman-Vozari R
    Curr Pharm Des; 2011; 17(5):489-507. PubMed ID: 21375482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Mobile Apps for Self-care in People With Parkinson Disease: Systematic Review.
    Lee J; Yeom I; Chung ML; Kim Y; Yoo S; Kim E
    JMIR Mhealth Uhealth; 2022 Jan; 10(1):e33944. PubMed ID: 35060910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effects of an Individualized Smartphone-Based Exercise Program on Self-defined Motor Tasks in Parkinson Disease: Pilot Interventional Study.
    Gaßner H; Friedrich J; Masuch A; Jukic J; Stallforth S; Regensburger M; Marxreiter F; Winkler J; Klucken J
    JMIR Rehabil Assist Technol; 2022 Nov; 9(4):e38994. PubMed ID: 36378510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhancing Clinical Information Display to Improve Patient Encounters: Human-Centered Design and Evaluation of the Parkinson Disease-BRIDGE Platform.
    Brown EG; Schleimer E; Bledsoe IO; Rowles W; Miller NA; Sanders SJ; Rankin KP; Ostrem JL; Tanner CM; Bove R
    JMIR Hum Factors; 2022 May; 9(2):e33967. PubMed ID: 35522472
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a Biochemical Diagnosis of Parkinson Disease by Detection of α-Synuclein Misfolded Aggregates in Cerebrospinal Fluid.
    Shahnawaz M; Tokuda T; Waragai M; Mendez N; Ishii R; Trenkwalder C; Mollenhauer B; Soto C
    JAMA Neurol; 2017 Feb; 74(2):163-172. PubMed ID: 27918765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Special Issue on new therapeutic approaches to Parkinson disease.
    Fox SH; Brotchie JM
    Neuropharmacology; 2022 May; 208():108998. PubMed ID: 35150730
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process.
    Willis GL
    Rev Neurosci; 2008; 19(4-5):245-316. PubMed ID: 19145986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkinson disease and exercise.
    Earhart GM; Falvo MJ
    Compr Physiol; 2013 Apr; 3(2):833-48. PubMed ID: 23720332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic potentials of plant iridoids in Alzheimer's and Parkinson's diseases: A review.
    Dinda B; Dinda M; Kulsi G; Chakraborty A; Dinda S
    Eur J Med Chem; 2019 May; 169():185-199. PubMed ID: 30877973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.